GGOTX | RRMGX | GGOTX / RRMGX | |
Total Expense Ratio | 0.91 | 1.29 | 71% |
Annual Report Gross Expense Ratio | 1.12 | 1.29 | 87% |
Fund Existence | 18 years | 23 years | - |
Gain YTD | 9.623 | 2.036 | 473% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.02B | 26.8B | 4% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 6.47 | -7.41 | -87% |
Returns for 3 years | 40.19 | 17.64 | 228% |
Returns for 5 years | -11.27 | -2.50 | 451% |
Returns for 10 years | -29.60 | 25.14 | -118% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DBEF | 46.03 | -0.03 | -0.07% |
Xtrackers MSCI EAFE Hedged Equity ETF | |||
HYBL | 28.59 | -0.03 | -0.12% |
SPDR® Blackstone High Income ETF | |||
QQQT | 18.40 | -0.08 | -0.43% |
Defiance Nasdaq 100 Income Target ETF | |||
IHD | 6.18 | -0.03 | -0.48% |
VOYA EMERGING MARKETS HIGH Income DIVIDEND EQUITY FUND | |||
FTXH | 27.30 | -0.50 | -1.79% |
First Trust Nasdaq Pharmaceuticals ETF |